Irmak Guzel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Irmak Guzel has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Ahmet Furkan Süner
Dokuz Eylul Universitesi Tip Fakültesi
2 shared publicationsGül Ergör
Dokuz Eylul Universitesi Tip Fakültesi
2 shared publicationsYücel Demiral
Dokuz Eylul Universitesi Tip Fakültesi
2 shared publicationsÇağlar Irmak
Dokuz Eylul Universitesi Tip Fakültesi
2 shared publications- Ahmet Naci Emecen
Department of Public Health, Epidemiology Subsection, Faculty of Medicine, Dokuz Eylül University, Balçova, Izmir, Turkey
1 shared publication Alp Ergör
Dokuz Eylul Universitesi Tip Fakültesi
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 6610060
Genomic and Phylogenetic Dissection of SARS‐CoV‐2 Transmission Networks in Healthcare Workers
Understanding how SARS‐CoV‐2 circulates among healthcare workers (HCWs) is critical for maintaining safe hospitals and protecting communities. We retrospectively examined 93 archived nasopharyngeal swabs collected from SARS‐CoV‐2 positive HCWs and their close contacts at a Turkish university hospital between March 2020 and November 2021. Viral RNA was confirmed by RT‐PCR and sequenced with the QIAseq DIRECT SARS‐CoV‐2 workflow on an Illumina platform; genomes were aligned to the Wuhan‐H1 reference and analyzed with maximum‐likelihood phylogenetics. Sixty‐three individuals formed 20 epidemiologically defined clusters (40 HCWs, 23 contacts; mean age ≈ 34 years), most experiencing only mild or moderate illness. Sequencing quality improved as RT‐PCR cycle threshold values fell, and nearly 98% of each genome was covered at 10 × depth. Fourteen viral lineages were detected, yet samples from the same cluster differed by no more than two single‐nucleotide changes, indicating recent person‐to‐person spread. Phylogenetic reconstruction suggested single‐source introduction in three‐quarters of clusters, with the remainder reflecting multiple introductions. Observational data linked transmission events to inconsistent use of personal protective equipment and inadequate physical distancing in break rooms, shared offices, and household settings. By combining genomic and field evidence, this study clarifies the paths by which SARS‐CoV‐2 moved through a healthcare workforce, highlights the value of whole‐genome sequencing for outbreak resolution, and reinforces the continuing need for rigorous infection‐control practices even when overall case severity appears low to prevent future clusters and maintain healthcare resilience.
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 6610060
Open AccessGenomic and Phylogenetic Dissection of SARS‐CoV‐2 Transmission Networks in Healthcare Workers
Understanding how SARS‐CoV‐2 circulates among healthcare workers (HCWs) is critical for maintaining safe hospitals and protecting communities. We retrospectively examined 93 archived nasopharyngeal swabs collected from SARS‐CoV‐2 positive HCWs and their close contacts at a Turkish university hospital between March 2020 and November 2021. Viral RNA was confirmed by RT‐PCR and sequenced with the QIAseq DIRECT SARS‐CoV‐2 workflow on an Illumina platform; genomes were aligned to the Wuhan‐H1 reference and analyzed with maximum‐likelihood phylogenetics. Sixty‐three individuals formed 20 epidemiologically defined clusters (40 HCWs, 23 contacts; mean age ≈ 34 years), most experiencing only mild or moderate illness. Sequencing quality improved as RT‐PCR cycle threshold values fell, and nearly 98% of each genome was covered at 10 × depth. Fourteen viral lineages were detected, yet samples from the same cluster differed by no more than two single‐nucleotide changes, indicating recent person‐to‐person spread. Phylogenetic reconstruction suggested single‐source introduction in three‐quarters of clusters, with the remainder reflecting multiple introductions. Observational data linked transmission events to inconsistent use of personal protective equipment and inadequate physical distancing in break rooms, shared offices, and household settings. By combining genomic and field evidence, this study clarifies the paths by which SARS‐CoV‐2 moved through a healthcare workforce, highlights the value of whole‐genome sequencing for outbreak resolution, and reinforces the continuing need for rigorous infection‐control practices even when overall case severity appears low to prevent future clusters and maintain healthcare resilience.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Surgery
- Vol. 2025 (1) , 6687581
Candida Parapsilosis: a Rare Culprit of Shunt Infection in an Adult
Candida parapsilosis is an exceedingly rare cause of ventriculoperitoneal (VP) shunt infection, even in patients who have a history of long‐term antibiotic use, immune‐compromised newborns, and intensive care unit patients. We hereby report a case of a 53‐year‐old male who presented with subarachnoid hemorrhage and had a complicated postoperative course due to C. parapsilosis infection, and we discuss the pertinent clinical aspects.
- 1 January 2025
- Published by Wiley in Case Reports in Surgery
- Vol. 2025 (1) , 6687581
Open AccessCandida Parapsilosis: a Rare Culprit of Shunt Infection in an Adult
Candida parapsilosis is an exceedingly rare cause of ventriculoperitoneal (VP) shunt infection, even in patients who have a history of long‐term antibiotic use, immune‐compromised newborns, and intensive care unit patients. We hereby report a case of a 53‐year‐old male who presented with subarachnoid hemorrhage and had a complicated postoperative course due to C. parapsilosis infection, and we discuss the pertinent clinical aspects.
- Open Access
- 20 October 2023
- Published by Wiley
Neutralizing Antibody Dynamics and Correlation with Anti-RBD IgG Levels after CoronaVac Vaccine and Booster Immunization in Healthcare Workers
Introduction: Vaccine-induced neutralizing-antibodies(NAbs) are key forCOVID-19 protective-immunity. This study aimed to assess Nabs-dynamics during nine-month follow-up-period after primary-CoronaVac vaccination and booster-immunization and its correlation with anti-RBD-IgG-levels to evaluate vaccination-strategies. Material and Method: This prospective-cohort-study followed 226-healthcare-workers who received double-dose CoronaVac at a university-hospital. Serum samples were collected at four-different-time points after primary and booster(CoronaVac-BNT162b2) immunization. Antibody-levels were assessed by SARS-CoV-2-IgG-II-QUANT(Abbott, USA) and ACE2-RBD-Neutralization-Assay(Dia-Pro, Italy)tests. Factors affecting antibody-response were analyzed. Statistical analysis was performed with IBM-SPSS-22.0. Results: NAbs were detected in 79.2% of participants one-month after the second-dose of CoronaVac but decreased to 48.8% by the fourth-month and was influenced by smoking,BMI and the presence of chronic-diseases. Boosters,regardless of type, significantly raised Nab-levels. Heterologous-vaccination yielded higher NAb and anti-RBD-IgG responses. Single or double-BNT162b2 boosters resulted in similar NAb responses. A strong-correlation was found between anti-RBD-IgG response and Nabs-levels following CoronaVac-vaccination, leading to the determination of predictive IgG-thresholds for the presence-of Nab. The type of-booster influenced the correlation strength and threshold-value. Conclusion: Nabs-levels drop rapidly after primary double-dose CoronaVac-vaccination. Booster-doses significantly increase these levels while the combination of heterologous-vaccines ensures a higher-response. Anti-RBD-IgG levels can predict NAb response however the correlation varies by the type of-vaccine, the strength of the resulting Nab response and the time-since-vaccination.
- 20 October 2023
- Published by Wiley
Open AccessNeutralizing Antibody Dynamics and Correlation with Anti-RBD IgG Levels after CoronaVac Vaccine and Booster Immunization in Healthcare Workers
Introduction: Vaccine-induced neutralizing-antibodies(NAbs) are key forCOVID-19 protective-immunity. This study aimed to assess Nabs-dynamics during nine-month follow-up-period after primary-CoronaVac vaccination and booster-immunization and its correlation with anti-RBD-IgG-levels to evaluate vaccination-strategies. Material and Method: This prospective-cohort-study followed 226-healthcare-workers who received double-dose CoronaVac at a university-hospital. Serum samples were collected at four-different-time points after primary and booster(CoronaVac-BNT162b2) immunization. Antibody-levels were assessed by SARS-CoV-2-IgG-II-QUANT(Abbott, USA) and ACE2-RBD-Neutralization-Assay(Dia-Pro, Italy)tests. Factors affecting antibody-response were analyzed. Statistical analysis was performed with IBM-SPSS-22.0. Results: NAbs were detected in 79.2% of participants one-month after the second-dose of CoronaVac but decreased to 48.8% by the fourth-month and was influenced by smoking,BMI and the presence of chronic-diseases. Boosters,regardless of type, significantly raised Nab-levels. Heterologous-vaccination yielded higher NAb and anti-RBD-IgG responses. Single or double-BNT162b2 boosters resulted in similar NAb responses. A strong-correlation was found between anti-RBD-IgG response and Nabs-levels following CoronaVac-vaccination, leading to the determination of predictive IgG-thresholds for the presence-of Nab. The type of-booster influenced the correlation strength and threshold-value. Conclusion: Nabs-levels drop rapidly after primary double-dose CoronaVac-vaccination. Booster-doses significantly increase these levels while the combination of heterologous-vaccines ensures a higher-response. Anti-RBD-IgG levels can predict NAb response however the correlation varies by the type of-vaccine, the strength of the resulting Nab response and the time-since-vaccination.
- 18 August 2023
- Published by Elsevier in Immunology Letters
- Vol. 262, 1-6
Pre-infection antibody levels of vaccinated healthcare workers with SARS-CoV-2 breakthrough infection: A nested case-control study
- 18 August 2023
- Published by Elsevier in Immunology Letters
- Vol. 262, 1-6
Pre-infection antibody levels of vaccinated healthcare workers with SARS-CoV-2 breakthrough infection: A nested case-control study